290 related articles for article (PubMed ID: 25166211)
21. [Hypoxia induced HIF-1 accumulation and VEGF expression in gastric epithelial mucosa cell: involvement of ERK1/2 and PI3K/Akt].
Liu L; Ning X; Han S; Zhang H; Sun L; Shi Y; Sun S; Guo C; Yin F; Qiao T; Wu K; Fan D
Mol Biol (Mosk); 2008; 42(3):459-69. PubMed ID: 18702304
[TBL] [Abstract][Full Text] [Related]
22. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
[TBL] [Abstract][Full Text] [Related]
23. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
Gao N; Nester RA; Sarkar MA
Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
25. Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2.
Al Taleb Z; Petry A; Chi TF; Mennerich D; Görlach A; Dimova EY; Kietzmann T
J Mol Med (Berl); 2016 Oct; 94(10):1153-1166. PubMed ID: 27286880
[TBL] [Abstract][Full Text] [Related]
26. 14-3-3ζ up-regulates hypoxia-inducible factor-1α in hepatocellular carcinoma via activation of PI3K/Akt/NF-кB signal transduction pathway.
Tang Y; Lv P; Sun Z; Han L; Luo B; Zhou W
Int J Clin Exp Pathol; 2015; 8(12):15845-53. PubMed ID: 26884855
[TBL] [Abstract][Full Text] [Related]
27. Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.
Kumar SM; Yu H; Edwards R; Chen L; Kazianis S; Brafford P; Acs G; Herlyn M; Xu X
Cancer Res; 2007 Apr; 67(7):3177-84. PubMed ID: 17409425
[TBL] [Abstract][Full Text] [Related]
28. NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27
Antony S; Jiang G; Wu Y; Meitzler JL; Makhlouf HR; Haines DC; Butcher D; Hoon DS; Ji J; Zhang Y; Juhasz A; Lu J; Liu H; Dahan I; Konate M; Roy KK; Doroshow JH
Mol Carcinog; 2017 Dec; 56(12):2643-2662. PubMed ID: 28762556
[TBL] [Abstract][Full Text] [Related]
29. Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells.
Ma J; Han LZ; Liang H; Mi C; Shi H; Lee JJ; Jin X
Oncol Rep; 2014 Jul; 32(1):235-42. PubMed ID: 24859482
[TBL] [Abstract][Full Text] [Related]
30. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
[TBL] [Abstract][Full Text] [Related]
31. Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1α and causes decreased tolerance to hypoxic stress.
Ouyang W; Torigoe C; Fang H; Xie T; Frucht DM
J Biol Chem; 2014 Feb; 289(7):4180-90. PubMed ID: 24366872
[TBL] [Abstract][Full Text] [Related]
32. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
[TBL] [Abstract][Full Text] [Related]
33. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
Sun YZ; Cai N; Liu NN
Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
[TBL] [Abstract][Full Text] [Related]
34. Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells.
Befani CD; Vlachostergios PJ; Hatzidaki E; Patrikidou A; Bonanou S; Simos G; Papandreou CN; Liakos P
J Mol Med (Berl); 2012 Jan; 90(1):45-54. PubMed ID: 21909688
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible factor-1β (HIF-1β) is upregulated in a HIF-1α-dependent manner in 518A2 human melanoma cells under hypoxic conditions.
Mandl M; Kapeller B; Lieber R; Macfelda K
Biochem Biophys Res Commun; 2013 Apr; 434(1):166-72. PubMed ID: 23541582
[TBL] [Abstract][Full Text] [Related]
36. MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition.
Dai M; Miao ZH; Ren X; Tong LJ; Yang N; Li T; Lin LP; Shen YM; Ding J
J Cell Mol Med; 2010 Sep; 14(9):2281-91. PubMed ID: 19538463
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia Promotes Pancreatic Cancer Cell Dedifferentiation to Stem-Like Cell Phenotypes With High Tumorigenic Potential by the HIF-1α/Notch Signaling Pathway.
Mu R; Zou YK; Tu K; Wang DB; Tang D; Yu Z; Zhao L
Pancreas; 2021 May-Jun 01; 50(5):756-765. PubMed ID: 34016895
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion.
Chen J; Imanaka N; Chen J; Griffin JD
Br J Cancer; 2010 Jan; 102(2):351-60. PubMed ID: 20010940
[TBL] [Abstract][Full Text] [Related]
39. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
[TBL] [Abstract][Full Text] [Related]
40. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
